27-hydroxycholesterol has been researched along with Menopause in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortner, RT; Johnson, TS; Kaaks, R; Le Cornet, C; Lu, DL; Sookthai, D | 1 |
| Allison, M; Aragaki, AK; Eaton, C; Hoogeveen, RC; Hsia, J; Jackson, R; Johnson, KC; Kuller, L; Manson, JE; Martin, LW; Prentice, RL; Rossouw, JE; Trevisan, M | 1 |
| Carey, KD; Chen, LD; Kushwaha, RS; McGill, HC; Rice, KS | 1 |
3 other study(ies) available for 27-hydroxycholesterol and Menopause
| Article | Year |
|---|---|
Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Menopause; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Risk Factors | 2019 |
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Menopause; Middle Aged; Receptors, Estrogen; Risk Factors; Treatment Outcome | 2012 |
Effect of naturally reduced ovarian function on plasma lipoprotein and 27-hydroxycholesterol levels in baboons (Papio sp.).
Topics: Animals; Cholestanetriol 26-Monooxygenase; Cytochrome P-450 Enzyme System; Estrogens; Female; Follicle Stimulating Hormone; Hydroxycholesterols; Lipoproteins; Liver; Menopause; Ovarian Function Tests; Ovary; Papio; Progesterone; Steroid Hydroxylases | 1998 |